Brief: Medigene 9-Month EBITDA Loss Of EUR 18.6 Mln

Medigene AG

13/11/2019 06:40

Nov 13 (Reuters) - MEDIGENE AG  MDG1k.DE :
    * 9-MONTH REVENUE FROM CORE BUSINESS OF IMMUNOTHERAPIES
INCREASED
BY 32% TO EUR 6.2 M (9M 2018: EUR 4.7 M)
    * 9-MONTH EBITDA LOSS INCREASED AS ANTICIPATED BY 48% TO EUR
18.6
M (9M 2018: EUR 12.6 M)
    * 9M NET LOSS FOR PERIOD INCREASED AS EXPECTED BY 52% TO EUR
20.0
M (9M 2018: EUR 13.2 M)
    * CONFIRMATION OF FINANCIAL GUIDANCE 2019

Source text for Eikon:  ID:nPex3tnlKa 
Further company coverage:  MDG1k.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))